Myriad Genetics, Inc. (MYGN)
USD 13.25
(-4.12%)
USD 13.25
(-4.12%)
| Breakdown | 2022 | 2021 | 2020 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -106.3 Million | 18.2 Million | -26.9 Million | 83.7 Million | 83.7 Million | 115.9 Million |
| Net Income | -112 Million | -27.2 Million | -223.7 Million | 4.6 Million | 4.6 Million | 131 Million |
| Depreciation & Amortization | 52.7 Million | 62.8 Million | 71.4 Million | 73 Million | 73 Million | 54.4 Million |
| Deferred income taxes | -31.9 Million | -34.7 Million | -54.5 Million | 13.1 Million | 13.1 Million | -23.7 Million |
| Stock-based compensation | 38.1 Million | 36.3 Million | 24.3 Million | 33.5 Million | 33.5 Million | 27.1 Million |
| Change in working capital | -101.5 Million | 120.4 Million | 30.2 Million | -37.1 Million | -37.1 Million | -21.6 Million |
| Other non-cash items | 48.3 Million | -139.4 Million | 70.9 Million | -3.4 Million | -3.4 Million | -51.3 Million |
| Investing Cash Flow | -77.5 Million | 274.4 Million | 61.6 Million | -286.4 Million | -286.4 Million | -11.6 Million |
| Investments in PPE | -45.3 Million | -18 Million | -13.2 Million | -8.6 Million | -8.6 Million | -8.4 Million |
| Acquisitions | -57.2 Million | 379.1 Million | - | -278.5 Million | -278.5 Million | 8.4 Million |
| Investment purchases | -103.2 Million | -147.8 Million | - | -78.5 Million | -78.5 Million | -80.9 Million |
| Sales/Maturities of investments | 128.2 Million | 61.1 Million | - | 79.2 Million | 79.2 Million | 77.7 Million |
| Other Investing Activities | - | - | 74.8 Million | - | - | -8.4 Million |
| Financing Cash Flow | -8 Million | -150.6 Million | -1 Million | 182.3 Million | 182.3 Million | -95 Million |
| Debt repayment | - | -226.4 Million | -8.6 Million | -115 Million | -115 Million | -143 Million |
| Dividends payments | - | - | - | -340 Million | -340 Million | - |
| Common Stock Repurchased | - | - | -3.9 Million | -50 Million | -50 Million | - |
| Common Stock Issuance | 6.3 Million | 91.8 Million | - | 8.7 Million | 8.7 Million | 36.9 Million |
| Other Financing Activities | -14.3 Million | -16 Million | 11.5 Million | 678.6 Million | 338.6 Million | 11.1 Million |
| Accounts receivables | -10.3 Million | -8.8 Million | 28.9 Million | -18.2 Million | -18.2 Million | -39.2 Million |
| Accounts payables | -3.5 Million | 9.2 Million | - | 1.1 Million | 1.1 Million | 4 Million |
| Inventory | -2.9 Million | 1.6 Million | 1.3 Million | 8 Million | 8 Million | 7.9 Million |
| Other working capital | -84.8 Million | 118.4 Million | - | -28 Million | -28 Million | 5.7 Million |
| Cash at beginning of period | 258.8 Million | 117 Million | 93.2 Million | 110.9 Million | 110.9 Million | 102.4 Million |
| Cash at end of period | 66.4 Million | 258.4 Million | 163.7 Million | 93.2 Million | 93.2 Million | 110.9 Million |
| Capital Expenditure | -45.3 Million | -18 Million | -13.2 Million | -8.6 Million | -8.6 Million | -8.4 Million |
| Effect of forex changes on cash | -600 Thousand | -600 Thousand | 600 Thousand | 2.7 Million | 2.7 Million | -800 Thousand |
| Net cash flow / Change in cash | -192.4 Million | 141.4 Million | 70.5 Million | -17.7 Million | -17.7 Million | 8.5 Million |
| Free Cash Flow | -151.6 Million | 200 Thousand | -40.1 Million | 75.1 Million | 75.1 Million | 107.5 Million |
| Breakdown | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 | 2022 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -61.3 Million | -116.1 Million | -54.7 Million | -112 Million | -42.3 Million | -35.1 Million |
| Depreciation & Amortization | 14.1 Million | 13.3 Million | 19.4 Million | 52.7 Million | 13.7 Million | 13.1 Million |
| Deferred income taxes | -500 Thousand | -400 Thousand | 2 Million | -31.9 Million | -10 Million | -11.1 Million |
| Stock-based compensation | 11.6 Million | 11.2 Million | 7.5 Million | 38.1 Million | 8.2 Million | 9.4 Million |
| Change in working capital | 9.8 Million | 82.8 Million | -24.3 Million | -101.5 Million | 4.7 Million | 8.4 Million |
| Other non-cash items | 4.2 Million | 8.3 Million | 16.9 Million | 48.3 Million | 18 Million | 13.5 Million |
| Investing Cash Flow | -2.5 Million | 11.8 Million | 34.6 Million | -77.5 Million | -35.6 Million | 11.4 Million |
| Investments in PPE | -17.5 Million | -18.8 Million | -23.5 Million | -45.3 Million | -14.6 Million | -17.7 Million |
| Acquisitions | - | - | - | -57.2 Million | -57.2 Million | - |
| Investment purchases | - | - | - | -103.2 Million | -4.4 Million | -13.3 Million |
| Sales/Maturities of investments | 15 Million | 30.6 Million | 58.1 Million | 128.2 Million | 40.6 Million | 42.4 Million |
| Other Investing Activities | -6.6 Million | - | - | - | - | - |
| Financing Cash Flow | -2.5 Million | 38.4 Million | -4.9 Million | -8 Million | -2.1 Million | -3.6 Million |
| Debt repayment | -2.5 Million | 33.5 Million | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | 6.3 Million | 3 Million | - |
| Other Financing Activities | - | 4.9 Million | -4.9 Million | -14.3 Million | -5.1 Million | -3.6 Million |
| Accounts receivables | -3.6 Million | 7.4 Million | -17.5 Million | -10.3 Million | 2.5 Million | 6.1 Million |
| Accounts payables | -8.5 Million | 3.1 Million | 7.6 Million | -3.5 Million | -2.4 Million | 7.1 Million |
| Inventory | -2.7 Million | -600 Thousand | -1.7 Million | -2.9 Million | 1.5 Million | -4.3 Million |
| Other working capital | 24.6 Million | 72.9 Million | -12.7 Million | -84.8 Million | 3.1 Million | -500 Thousand |
| Cash at beginning of period | 112.7 Million | 63.1 Million | 66.4 Million | 258.8 Million | 110.7 Million | 105.2 Million |
| Cash at end of period | 85 Million | 112.7 Million | 63.1 Million | 66.4 Million | 66.4 Million | 110.7 Million |
| Capital Expenditure | -17.5 Million | -18.8 Million | -23.5 Million | -45.3 Million | -14.6 Million | -17.7 Million |
| Effect of forex changes on cash | -600 Thousand | 300 Thousand | 200 Thousand | -600 Thousand | 700 Thousand | -500 Thousand |
| Net cash flow / Change in cash | -27.7 Million | 49.6 Million | -3.3 Million | -192.4 Million | -44.3 Million | 5.5 Million |
| Free Cash Flow | -39.6 Million | -19.7 Million | -56.7 Million | -151.6 Million | -22.3 Million | -19.5 Million |
5602
AZASF
SNDX
0DH7
ADT
ADP